NecstGen

Leiden, NL
Find alternatives to NecstGen for AAV →
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
78.1
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ✓ EMA GMP (1) ○ MHRA GMP

Quick Facts: NecstGen

Signal Score
78.1/100 (as of 2026-10-29)
Quality Compliance
100.0/100
Headquarters
Leiden, NL
Modalities
AAV, Lentiviral, Cell Therapy
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About NecstGen

Dutch CGT CDMO focused on clinical manufacturing.

Signal Score & Pillar Breakdown

Quality Compliance 100.0
FDA InspectionsNo US records on file
EMA GMP Certificates1 on record
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
1 manufacturing site: Leiden, Netherlands
Modalities: AAV, Lentiviral, Cell Therapy
Capacity assessment: 58.0/100
Sites: Leiden, Netherlands
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: Leiden, Netherlands
Modalities: AAV, Lentiviral, Cell Therapy
Capacity assessment: 58.0/100

NecstGen EMA GMP Compliance 1 certificates

2025-11
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
NL/H 25/2055354 NECSTGEN Therapies Netherlands 2025-11-11 COMPLIANT
Source: EMA EudraGMDP · Retrieved Nov 21, 2026

Hiring Activity Beta

From public job postings on NecstGen's careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No open roles were listed on Nov 20, 2026.
Coverage: counted from NecstGen's own careers board. Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source: recruitee · Checked Nov 20, 2026 · Tracking since Oct 26, 2026

Frequently Asked Questions About NecstGen

Does NecstGen hold EMA or MHRA GMP certificates?
CDMO Signal tracks 1 EMA GMP certificate for NecstGen.
What is NecstGen's CDMO Signal Score?
NecstGen has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating NecstGen for a manufacturing program?
Use the free AI matchmaker to compare NecstGen against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → Lentiviral CDMOs → Cell Therapy CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 79.9
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation
SK pharmteco
Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Signal Score: 79.5
Viral Vectors, AAV, Lentiviral, Adenoviral, HPAPIs, Small Molecules, Peptides, BioCatalysis, Chromatography, Cell Therapy
Lonza
Basel, Switzerland
Signal Score: 72.8
AAV, Lentiviral, Cell Therapy, mRNA, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation, Small Molecule API, High-Potency APIs, Oral Solid Dose
Rose BioSolutions
Rockville, MD · Memphis, TN · Keele, United Kingdom
Signal Score: 64.0
AAV, Lentiviral, Adenoviral, Plasmid, Cell Therapy, CAR-T

Compare NecstGen with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on NecstGen
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.